Investment Thesis
Privia Health exhibits fundamental operational deterioration masked by revenue growth. Despite 22.3% YoY revenue expansion to $603.8M, the company posted -$49.5M operating cash flow and -$49.6M free cash flow, indicating the core business is not generating cash. Net income declined 22.9% YoY while revenue grew, revealing severe margin compression and unsustainable unit economics.
Strengths
- Strong revenue growth of 22.3% YoY demonstrates market demand and business expansion
- Fortress balance sheet with minimal leverage (0.04x debt-to-equity) and $419.5M cash provides financial flexibility to address operational challenges
- Excellent interest coverage of 14.8x and low absolute debt ($33.0M) eliminate near-term solvency risk
Risks
- Negative operating cash flow of -$49.5M indicates core business is destroying cash despite revenue generation; at current burn rate provides approximately 8.5 years of runway before cash depletion
- Margin compression is severe: net income declined 22.9% YoY while revenue grew 22.3%, signaling deteriorating profitability and unit economics despite scale
- Profitability metrics are critically low (operating margin 1.2%, net margin 0.5%, ROE 0.4%, ROA 0.2%), suggesting fundamental business model inefficiency in healthcare services delivery
Key Metrics to Watch
- Operating cash flow trend - must return to positive; continued negative OCF is structurally unsustainable
- Operating margin and net margin trajectory - assess whether scale improvements can reverse margin compression
- Cash burn rate by quarter - monitor path to cash flow breakeven and assess runway adequacy
Financial Metrics
Revenue
603.8M
Net Income
3.1M
EPS (Diluted)
$0.02
Free Cash Flow
-49.6M
Total Assets
1.4B
Cash
419.5M
Profitability Ratios
Gross Margin
N/A
Operating Margin
1.2%
Net Margin
0.5%
ROE
0.4%
ROA
0.2%
FCF Margin
-8.2%
Balance Sheet & Liquidity
Current Ratio
1.61x
Quick Ratio
1.61x
Debt/Equity
0.04x
Debt/Assets
43.2%
Interest Coverage
14.84x
Long-term Debt
33.0M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-09T12:39:14.059795 |
Data as of: 2026-03-31 |
Powered by Claude AI